Acute modulation of active carrier-mediated brain-to-blood transport of corticotropin-releasing hormone

American Journal of Physiology - Endocrinology and Metabolism

Volumn 272, Issue 2 35-2, 1997, Pages

  Martins, J Martin ^a   Banks, William A ^a,b   Kastin, Abba J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

adrenal steroids; blood brain barrier; cytokines; endogenous opiates

Indexed keywords

BETA ENDORPHIN; CALCIUM CHANNEL; CORTICOSTEROID; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE TRANSPORT; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; HORMONE TRANSPORT; MALE; MICROTUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS; TRANSPORT KINETICS;

EID: 0030896216     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.272.2.e312     Document Type: Article

References (38)

1. Banks, W. A., and R. D. Broadwell. Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutinin, and albumin: pharmacokinetic and morphological assessments. J. Neurochem. 62: 2404-2419, 1994.
2. Banks, W. A., and A. J. Kastin. Quantifying carrier-mediated transport of peptides from the brain to the blood. Methods Enzymol. 168: 652-660, 1989.
3. Banks, W. A., and A. J. Kastin. Peptide transport systems for opiates across the blood-brain barrier. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E1-E10, 1990.
4. Banks, W. A., and A. J. Kastin. Measurement of transport of cytokines across the blood-brain barrier. Methods Neurosci. 16: 67-77, 1993.
5. Banks, W. A., and A. J. Kastin. Brain-to-blood transport of peptides and the alcohol withdrawal syndrome. In: Models of Neuropeptide Action, edited by F. L. Strand, B. Beckwith, B. Chronwall, and C. A. Sandman. New York: NYAcad. Sci., 1994, p. 108-118.
6. Banks, W. A., A. J. Kastin, M. B. Fasold, C. M. Barrera, and G. Augereau. Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier. Brain Res. Bull. 21: 881-885, 1988.
7. Behan, D. P., E. B. De Souza, E. Potter, P. Sawchenko, P. J. Lowry, and W. W. Vale. Modulatory actions of corticotropin-releasing factor-binding protein. In: Neuropeptides: Basic and Clinical Advances, edited by J. N. Crawley and S. McLean. New York: NY Acad. Sci., 1996, p. 81-95.
8. Behan, D. P., S. C. Heinrichs, J. C. Troncoso, X.-J. Liu, C. H. Kawas, N. Ling, and E. B. De Souza. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature Lond. 378: 284-287, 1995.
9. Benet, L. Z., J. R. Mitchell, and L. B. Sheiner. Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: The Pharmacological Basis of Therapeutics, edited by A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor. New York: Pergamon, 1990, p. 1-32.
10. Biller, B. M. K., H. J. Federoff, J. I. Koenig, and A. Klibanski. Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 70: 311-317, 1990.
11. Bouchard, C., J.-P. Despres, and P. Mauriege. Genetic and nongenetic determinants of regional fat distribution. Endocr. Rev. 14: 72-93, 1993.
12. Bruhn, T. O., P. M. Plotsky, and W. W. Vale. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF. Endocrinology 114: 57-62, 1984.
13. Calogero, A. E., W. T. Gallucci, P. W. Gold, and G. P. Chrousos. Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. J. Clin. Invest. 82: 767-774, 1988.
14. Campbell, E. A., E. A. Linton, C. D. A. Wolfe, P. R. Scarggs, M. T. Jones, and P. J. Lowry. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab. 64: 1054-1059, 1987.
15. Chrousos, G. P., and P. W. Gold. The concepts of stress and stress system disorders. J. Am. Med. Assoc. 267: 1244-1252, 1992.
16. Davson, H., and M. B. Segal. The blood-cerebrospinal fluid barrier. In: Physiology of the CSF and Blood-Brain Barriers, edited by H. Davson and M. B. Segal. Boca Raton, FL: CRC, 1996, p. 25-47.
17. Geracioti, T. D., D. N. Orth, N. N. Ekhator, B. Blumenkopf, and P. T. Loosen. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J. Clin. Endocrinol. Metab. 74: 1325-1330, 1992.
18. Hennessy, M. B., S. J. Long, and D. J. Nolan. Effects of peripherally administered corticotropin-releasing factor (CRF) and a CRF antagonist: does peripheral CRF activity mediate behavior of guinea pig pups during isolation? Behav. Neurosci. 109: 1137-1145, 1995.
19. Johnson, R. W., E. H. Borell, L. L. Anderson, L. D. Kojic, and J. E. Cunnick. Intracerebroventricular injection of corticotropin-releasing hormone in the pig: acute effects on behavior, adrenocorticotropin secretion, and immune suppression. Endocrinology 135: 642-648, 1994.
20. Joo, F., I. Lengyel, J. Kovacs, and B. Penke. Regulation of transendothelial transport in the cerebral microvessels: the role of second messengers-generating systems. Prog. Brain Res. 91: 177-187, 1992.
21. Kaback, H. R. Molecular biology of active transport: from membrane to molecule to mechanism. Harvey Lect. 83: 77-105, 1989.
22. Karakis, K., H. Sano, J. Redwine, S. Listwak, R. L. Wilder, and G. P. Chrousos. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science Wash. DC 254: 421-423, 1991.
23. Kastin, A. J., L. C. Honour, J. Sueiras-Dias, and D. H. Coy. Opposite effects of CRF and ACTH on reserpine-induced hypothermia. Pharmacol. Biochem. Behav. 17: 1203-1206, 1982.
24. Kavelaars, A., F. Berkenbosch, G. Croiset, R. E. Ballicux, and C. J. Heijnen. Induction of β-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 126: 759-764, 1990.
25. Linton, E. A., and P. J. Lowry. Radioimmunoassay and chromatographic characterisation of CRF-41-like immunoreactivity in hypothalami from several species. Neuropeptides 3: 45-52, 1982.
26. Martins, J. M., A. J. Kastin, and W. A. Banks. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology 63: 338-348, 1996.
27. Petrusz, P., I. Merchenthaler, J. L. Maderdrut, and P. U. Heitz. Central and peripheral distribution of corticotropin-releasing factor. Federation Proc. 44: 229-235, 1985.
28. Reul, J. M., F. R. Bosch, and E. R. De Kloet. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J. Endocrinol. 115: 459-467, 1987.
29. Salacinski, P. R. P., C. McLean, J. E. Sykes, V. V. Clement-Jones, and P. J. Lowry. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3,6-diphenyl glycoluril (Iodogen). Anal. Biochem. 117: 136-146, 1981.
30. Sapolsky, R. M., L. C. Krey, and B. S. McEwen. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7: 284-301, 1986.
31. Sapolsky, R., C. Rivier, G. Yamamoto, P. Plotsky, and W. Vale. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science Wash. DC 238: 522-524, 1987.
32. Shirai, A., M. Naito, T. Tatsuta, J. Dong, K. Hanaoka, K. Mikami, T. Oh-hara, and T. Tsuruo. Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein. Biochim. Biophys. Acta 1222: 400-404, 1994.
33. Sternberg, E. M., J. M. Hill, G. P. Chrousos, T. Kamilaris, S. J. Listwak, P. W. Gold, and R. L. Wilder. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. USA 86: 2374-2378, 1989.
34. Suda, T., M. Iwasita, T. Sumitomo, Y. Nakanao, F. Tozawa, T. Ushiyama, and H. Demura. Glucocorticoids decrease binding of CRF-BP in human plasma. J. Clin. Endocrinol. Metab. 71: 913-917, 1990.
35. Tilders, F. J. H., R. H. DeRijk, A.-M. Van Dam, V. A. M. Vicent, K. Schotanus, and J. H. A. Persoons. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology 19: 209-232, 1994.
36. Ulisse, S., A. Fabbri, and M. L. Dufau. Corticotropin-releasing factor receptors and actions in rat Leydig cells. J. Biol. Chem. 264: 2156-2163, 1989.
37. Wilson, L. Microtubules as drug receptors: pharmacological properties of microtubule protein. In: The Biology of Cytoplasmic Microtubules, edited by D. Soifer. New York: NY Acad. Sci., 1975, p. 213-231.
38. Woods, R. J., P. Grossman, P. Saphier, K. Kennedy, E. Ur, D. Behan, E. Potter, W. Vale, and P. J. Lowry. Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex. J. Clin. Endocrinol. Metab. 78: 73-76, 1994.